Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Feb 19, 2021 10:00 AM - Feb 19, 2021 11:00 AM

Online

DIA DIRECT: The New Norm: Remote Monitoring of Sites and Patients

The adoption of remote monitoring requires virtual access to sites, data, and patients. What should sponsors assess before making the switch to a fully remote model?

Presenters

Nimita  Limaye, PhD

Nimita Limaye, PhD

Research VP, Life Sciences R&D Strategy and Technology, at IDC, IDC, United States

Dr. Nimita Limaye provides strategic advisory and market analysis on key topics related to Life Sciences R&D Strategy and Technology, and is IDC's primary life sciences AI analyst. An executive business leader with over three decades of life sciences leadership experience, spanning pharma, CRO, and tech consulting, she has led business strategy and managed large global operations. An extremely well networked thought leader, she has been ranked amongst the top 50 analysts in the AR100 Market Amplifiers Power 100 list in Q4 2025. She was the recipient of the 2024 DIA Global Inspire Award and has served as the past chair of the SCDM board. She is the current chair of the DIA Global Medical Writing community.

Andrea  Bastek, PhD, MS

Andrea Bastek, PhD, MS

VP Market Strategy, Florence Healthcare, United States

Andrea Bastek, Ph.D., is VP of Market Strategy at Florence Healthcare. Her team works to drive transformation in the eClinical industry in order to improve the site experience and the collaboration between sites and Sponsors/CROs. Prior to Florence she spent 15 years supporting sites running cardiac medical device studies working with and leading a unique sponsor field team. She holds a Ph.D. in Bioengineering from The Georgia Institute of Technology as well as a BS and MS in Biomedical Engineering from Tulane University.

Andreas  Beust

Andreas Beust

Head, Biostatistics, GCP-Service International, Germany

Andreas Beust is the Head of the Biostatistics team at the CRO GCP-Service International, which he joined in 2017. In his role as a statistician, he participated in more than three dozen clinical trials of medicinal products (Phase I through III) and medical devices (pre- and post-marketing). Additionally, Andreas obtained some experience as data manager and project manager. This shaped his perspective on how monitoring is approached and fueled the desire to combine centralized statistical analysis of trial data with improvement of data quality and monitoring processes.

Ioannis  Chatziioannidis

Ioannis Chatziioannidis

Owner and CEO, EOS Consulting, Greece

After 25 years in the Hellenic Air Force and NATO, Ioannis Chatziioannidis served as the Information Security Advisor in a multinational CRO with focus on data security of clinical trials. Ioannis has certified more than 115 companies across the globe, performing audits for ISO:27001 (Information Security), ISO:9001 (Quality Management), ISO:20000 (Service Management), and ISO:22301 (Business Continuity). He was the consultant on more than 55 GDPR Compliance projects and implemented various Management Systems, focusing on information security. Ioannis has recently been appointed by a US-based NPO-Beneficiary Organization as their Europe-wide Data Protection Officer (DPO), performing international research specialized in psychiatric trauma.

Lauren Sine Litzinger

Lauren Sine Litzinger

Process, Standards & Signal Interpretation Group Lead, Global Site & Study Ops, Pfizer, United States

Lauren Litzinger is the Standards Team Lead and Site Monitoring Business Process Owner within Global Site and Study Operations at Pfizer. Global Site and Study Operations drives study and site operational activities, including study management and site monitoring. Lauren has worked for Pfizer for over 20 years, starting as a Site Monitor and changing roles within the operational line to her current role, driving process consistency and implementation.

Susanna  Sellmann

Susanna Sellmann

Program Director, Cancer Clinical Research Unit, Princess Margaret Cancer Program, Canada

A medical radiation therapist by training, Susanna transitioned to oncology clinical research in the late 90s, then shifted gears to research administration in the early 2000s. Susanna’s roles have included organizing and running trial data management, institutional clinical trial regulatory compliance, and implementing a program-wide quality assurance and audit program. As program director, Susanna is actively involved in the day-to-day operations of the Cancer Clinical Research Unit, program development, and strategic planning. In 2006, Susanna established the Toronto SOCRA chapter to facilitate certified clinical research professionals’ access to continuing education credit. She has since become a board member and the President of SOCRA.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.